Author Voors, Adriaan A.

1 to 34 of 34 Items
  • 2006 | Journal Article
    ​ ​Rationale and design of a study to evaluate management of proteinuria in patients at high risk for vascular events: the IMPROVE trial​
    Bakris, G. L.; Ruilope, L.; Locatelli, F.; Ptaszynska, A.; Pieske, B. M.; Raz, I. & Voors, A. A. et al.​ (2006) 
    Journal of Human Hypertension, 20(9) pp. 693​-700​.​ DOI: https://doi.org/10.1038/sj.jhh.1002050 
    ​Details  DOI  PMID  PMC  WoS 
  • 2015 | Journal Article
    ​ ​Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease​
    Pitt, B.; Anker, S.-D.; Boehm, M.; Gheorghiade, M.; Kober, L.; Krum, H. & Maggioni, A. P. et al.​ (2015) 
    European Journal of Heart Failure, 17(2) pp. 224​-232​.​ DOI: https://doi.org/10.1002/ejhf.218 
    ​Details  DOI  PMID  PMC  WoS 
  • 2015 | Journal Article
    ​ ​Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial​
    Tang, W. H. W.; Dupont, M.; Hernandez, A. F.; Voors, A. A.; Hsu, A. P.; Felker, G. M. & Butler, J. et al.​ (2015) 
    JACC Heart Failure, 3(1) pp. 40​-49​.​ DOI: https://doi.org/10.1016/j.jchf.2014.06.014 
    ​Details  DOI  PMID  PMC  WoS 
  • 2016 | Journal Article | Erratum
    ​ ​Erratum to “Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency” [Eur J Heart Fail 2016;18:482-489]​
    Anker, S. D. ; Schroeder, S.; Atar, D.; Bax, J. J.; Ceconi, C.; Cowie, M. R. & Crisp, A. et al.​ (2016) 
    European Journal of Heart Failure, 18(6) pp. 727​-727​.​ DOI: https://doi.org/10.1002/ejhf.591 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure​
    Ponikowski, P.; Voors, A. A.; Anker, S. D. ; Bueno, H.; Cleland, J. G. F.; Coats, A. J. S. & Falk, V. et al.​ (2016) 
    European Journal of Heart Failure, 18(8) pp. 891​-975​.​ DOI: https://doi.org/10.1002/ejhf.592 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF​
    Voors, A. A.; Anker, S. D. ; Cleland, J. G.; Dickstein, K.; Filippatos, G.; van der Harst, P. & Hillege, H. L. et al.​ (2016) 
    European Journal of Heart Failure, 18(6) pp. 716​-726​.​ DOI: https://doi.org/10.1002/ejhf.531 
    ​Details  DOI 
  • 2016 | Review | 
    ​ ​Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency​
    Anker, S.-D.; Schroeder, S.; Atar, D.; Bax, J. J.; Ceconi, C.; Cowie, M. R.& AdamCrisp, A. et al.​ (2016)
    European Journal of Heart Failure, 18​(5) pp. 482​-489​.​
    Wiley-blackwell. DOI: https://doi.org/10.1002/ejhf.516 
    ​Details  DOI  PMID  PMC  WoS 
  • 2016 | Journal Article | 
    ​ ​A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease​
    Filippatos, G. S.; Anker, S.-D.; Boehm, M.; Gheorghiade, M.; Kober, L.; Krum, H. & Maggioni, A. P. et al.​ (2016) 
    European Heart Journal, 37(27) pp. 2105​-2114​.​ DOI: https://doi.org/10.1093/eurheartj/ehw132 
    ​Details  DOI  PMID  PMC  WoS 
  • 2017 | Journal Article
    ​ ​Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure​
    Voors, A. A.; Ouwerkerk, W.; Zannad, F.; van Veldhuisen, D. J.; Samani, N. J.; Ponikowski, P. & Ng, L. L. et al.​ (2017) 
    European Journal of Heart Failure, 19(5) pp. 627​-634​.​ DOI: https://doi.org/10.1002/ejhf.785 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure​
    Bayes-Genis, A.; Núñez, J.; Zannad, F.; Ferreira, J. P.; Anker, S. D. ; Cleland, J. G. & Dickstein, K. et al.​ (2017) 
    Journal of the American College of Cardiology, 70(17) pp. 2128​-2136​.​ DOI: https://doi.org/10.1016/j.jacc.2017.08.057 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure​
    Emmens, J. E.; Jones, D. J.; Cao, T. H.; Chan, D. C.; Romaine, S. P.; Quinn, P. A. & Anker, S. D.  et al.​ (2017) 
    European Journal of Heart Failure, 20(2) pp. 260​-267​.​ DOI: https://doi.org/10.1002/ejhf.1101 
    ​Details  DOI 
  • 2017 | Journal Article | 
    ​ ​Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency​
    van Veldhuisen, D. J.; Ponikowski, P.; van der Meer, P.; Metra, M.; Böhm, M.; Doletsky, A. & Voors, A. A. et al.​ (2017) 
    Circulation, 136(15) pp. 1374​-1383​.​ DOI: https://doi.org/10.1161/CIRCULATIONAHA.117.027497 
    ​Details  DOI 
  • 2017 | Journal Article | 
    ​ ​Expert consensus document: Mitochondrial function as a therapeutic target in heart failure​
    Brown, D. A.; Perry, J. B.; Allen, M. E.; Sabbah, H. N.; Stauffer, B. L.; Shaikh, S. R. & Cleland, J. G. F. et al.​ (2017) 
    Nature Reviews Cardiology, 14(4) pp. 238​-250​.​ DOI: https://doi.org/10.1038/nrcardio.2016.203 
    ​Details  DOI  PMID  PMC 
  • 2018 | Journal Article
    ​ ​Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction​
    Streng, K. W.; Nauta, J. F.; Hillege, H. L.; Anker, S. D. ; Cleland, J. G.; Dickstein, K. & Filippatos, G. et al.​ (2018) 
    International Journal of Cardiology, 271 pp. 132​-139​.​ DOI: https://doi.org/10.1016/j.ijcard.2018.04.001 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF​
    Beusekamp, J. C.; Tromp, J.; van der Wal, H. H.; Anker, S. D. ; Cleland, J. G.; Dickstein, K. & Filippatos, G. et al.​ (2018) 
    European Journal of Heart Failure, 20(5) pp. 923​-930​.​ DOI: https://doi.org/10.1002/ejhf.1079 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure​
    ter Maaten, J. M.; Voors, A. A.; Damman, K.; van der Meer, P.; Anker, S. D.; Cleland, J. G. & Dickstein, K. et al.​ (2018) 
    International Journal of Cardiology, 253 pp. 84​-90​.​ DOI: https://doi.org/10.1016/j.ijcard.2017.10.010 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure​
    Ouwerkerk, W.; Zwinderman, A. H.; Ng, L. L.; Demissei, B.; Hillege, H. L.; Zannad, F. & van Veldhuisen, D. J. et al.​ (2018) 
    Journal of the American College of Cardiology, 71(4) pp. 386​-398​.​ DOI: https://doi.org/10.1016/j.jacc.2017.11.041 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study​
    Ferreira, J. P.; Metra, M.; Anker, S. D. ; Dickstein, K.; Lang, C. C.; Ng, L. & Samani, N. J. et al.​ (2019) 
    European Journal of Heart Failure, 21(2) pp. 218​-226​.​ DOI: https://doi.org/10.1002/ejhf.1380 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Bio‐adrenomedullin as a marker of congestion in patients with new‐onset and worsening heart failure​
    ter Maaten, J. M.; Kremer, D.; Demissei, B. G.; Struck, J.; Bergmann, A.; Anker, S. D.   & Ng, L. L. et al.​ (2019) 
    European Journal of Heart Failure, 21(6) pp. 732​-743​.​ DOI: https://doi.org/10.1002/ejhf.1437 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Association with outcomes and response to treatment of trimethylamine N‐oxide in heart failure: results from BIOSTAT‐CHF​
    Suzuki, T.; Yazaki, Y.; Voors, A. A.; Jones, D. J.; Chan, D. C.; Anker, S. D.   & Cleland, J. G. et al.​ (2019) 
    European Journal of Heart Failure, 21(7) pp. 877​-886​.​ DOI: https://doi.org/10.1002/ejhf.1338 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure​
    Emmens, J. E.; ter Maaten, J. M.; Damman, K.; van Veldhuisen, D. J.; de Boer, R. A.; Struck, J. & Bergmann, A. et al.​ (2019) 
    Circulation: Heart Failure, 12(5).​ DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.118.005544 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment​
    Nauta, J. F.; Hummel, Y. M.; Tromp, J.; Ouwerkerk, W.; van der Meer, P.; Jin, X. & Lam, C. S. et al.​ (2019) 
    European Journal of Heart Failure, 22(7) pp. 1147​-1155​.​ DOI: https://doi.org/10.1002/ejhf.1632 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study​
    Markousis‐Mavrogenis, G.; Tromp, J.; Ouwerkerk, W.; Devalaraja, M.; Anker, S. D. ; Cleland, J. G. & Dickstein, K. et al.​ (2019) 
    European Journal of Heart Failure, 21(8) pp. 965​-973​.​ DOI: https://doi.org/10.1002/ejhf.1482 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Geographical location affects the levels and association of trimethylamine N‐oxide with heart failure mortality in BIOSTAT‐CHF: a post‐hoc analysis​
    Yazaki, Y.; Salzano, A.; Nelson, C. P.; Voors, A. A.; Anker, S. D. ; Cleland, J. G. & Lang, C. C. et al.​ (2019) 
    European Journal of Heart Failure, 21(10) pp. 1291​-1294​.​ DOI: https://doi.org/10.1002/ejhf.1550 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach​
    Hoes, M. F.; Tromp, J.; Ouwerkerk, W.; Bomer, N.; Oberdorf‐Maass, S. U.; Samani, N. J. & Ng, L. L. et al.​ (2019) 
    European Journal of Heart Failure, 22(11) pp. 2102​-2111​.​ DOI: https://doi.org/10.1002/ejhf.1674 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article
    ​ ​Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study​
    Ferreira, J. P.; Metra, M.; Mordi, I.; Gregson, J.; Ter Maaten, J. M.; Tromp, J. & Anker, S. D.  et al.​ (2019) 
    European Journal of Heart Failure, 21(1) pp. 112​-120​.​ DOI: https://doi.org/10.1002/ejhf.1323 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article | 
    ​ ​Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation​
    Mordi, I. R.; Santema, B. T.; Kloosterman, M.; Choy, A.-M.; Rienstra, M.; van Gelder, I. & Anker, S. D. et al.​ (2019) 
    Clinical Research in Cardiology, pp. 1​-9​.​ DOI: https://doi.org/10.1007/s00392-018-1409-x 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article | 
    ​ ​Selenium and outcome in heart failure​
    Bomer, N.; Grote Beverborg, N.; Hoes, M. F.; Streng, K. W.; Vermeer, M.; Dokter, M. M. & IJmker, J. et al.​ (2019) 
    European Journal of Heart Failure, 22(8) pp. 1415​-1423​.​ DOI: https://doi.org/10.1002/ejhf.1644 
    ​Details  DOI  PMID  PMC 
  • 2020 | Journal Article
    ​ ​Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF​
    Kobayashi, M.; Voors, A. A.; Girerd, N.; Billotte, M.; Anker, S. D. ; Cleland, J. G. & Lang, C. C. et al.​ (2020) 
    European Journal of Internal Medicine, 71 pp. 62​-69​.​ DOI: https://doi.org/10.1016/j.ejim.2019.10.017 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction​
    ter Maaten, J. M.; Martens, P.; Damman, K.; Dickstein, K.; Ponikowski, P.; Lang, C. C. & Ng, L. L. et al.​ (2020) 
    Clinical Research in Cardiology, 109(8) pp. 1048​-1059​.​ DOI: https://doi.org/10.1007/s00392-020-01598-w 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT‐CHF​
    Israr, M. Z.; Salzano, A.; Yazaki, Y.; Voors, A. A.; Ouwerkerk, W.; Anker, S. D. & Cleland, J. G. et al.​ (2020) 
    European Journal of Heart Failure, 22(8) pp. 1486​-1490​.​ DOI: https://doi.org/10.1002/ejhf.1951 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​A Clinical Tool to Predict Low Serum Selenium in Patients with Worsening Heart Failure​
    Al-Mubarak, A. A.; Grote Beverborg, N.; Anker, S. D.; Samani, N. J.; Dickstein, K.; Filippatos, G. & van Veldhuisen, D. J. et al.​ (2020) 
    Nutrients, 12(9) pp. 2541​.​ DOI: https://doi.org/10.3390/nu12092541 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)​
    Pieske, B. ; Tschöpe, C.; Boer, R. A.; Fraser, A. G.; Anker, S. D. ; Donal, E. & Edelmann, F.  et al.​ (2020) 
    European Journal of Heart Failure, 22(3) pp. 391​-412​.​ DOI: https://doi.org/10.1093/eurheartj/ehz641 10.1002/ejhf.1741 
    ​Details  DOI; DOI 
  • 2021 | Journal Article
    ​ ​Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure​
    Boorsma, E. M.; Maaten, J. M.; Damman, K.; Veldhuisen, D. J.; Dickstein, K.; Anker, S. D.   & Filippatos, G. et al.​ (2021) 
    European Journal of Heart Failure,.​ DOI: https://doi.org/10.1002/ejhf.2158 
    ​Details  DOI 

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100